This is the limited version of the Genetrix company profile: Join LinkedIn or Sign In to see more information.
Genetrix SL engages in the translation of clinical and medical research results to medicine. It involves in developing and producing medicines based on the use of stem cells of adult origin; generating therapeutic molecules based on human antibodies for the treatment of infectious, degenerative, and inflammatory diseases; developing and commercializing drug-eluting stents coated with medicines which allow control of the vascular biology and avoid restenosis after stent implantation in heart attack patients; and developing and commercializing products for regeneration and prevention of uncontrolled growth of the heart tissue. The company was founded in 2001 and is based in Tres Cantos, Spain.
Your Connections to Genetrix
Popular Profiles at Genetrix
Calle Marconi 1
Parque Tecnolσgico de Madrid
Tres Cantos, Madrid
28760
Spain
Phone: 34 91 804 92 64
Fax: 34 91 804 92 63
Estimated based on LinkedIn Data
In partnership with 
Send feedback on BusinessWeek/CapIQ content to linkedinissues@capitaliq.com. Copyright © 2009 Capital IQ.
This LinkedIn Company Profile was created by LinkedIn and is about Genetrix. This page is not endorsed by or affiliated with Genetrix. For questions regarding LinkedIn Company Profiles, contact us.
| 